WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Related articles:
Related suggestion:
Efforts to Improve Child Development in Rural AreasCommission, Departments Help Children Improve Mental Well4th Asian Para Games Opens in Hangzhou, E ChinaScenic Area Opens to Promote Night Economy in XinjiangOverseas Chinese Talent Conference for Development Underway in East ChinaChinese Dragon Version of Bing Dwen Dwen UnveiledChina Releases White Paper on Belt and Road CooperationIce Rink Opens to Public in Tianjin, N ChinaThe Rural Girls Chasing Goals on Football PitchesChina continues to provide humanitarian assistance to Gaza
2.6647s , 6495.140625 kb
Copyright © 2024 Powered by 5 takeaways from the abortion pill case before the U.S. Supreme Court ,Cosmic Chronicle news portal